CN101193638A - 用于良性前列腺肥大疗法的组合 - Google Patents
用于良性前列腺肥大疗法的组合 Download PDFInfo
- Publication number
- CN101193638A CN101193638A CNA2006800207814A CN200680020781A CN101193638A CN 101193638 A CN101193638 A CN 101193638A CN A2006800207814 A CNA2006800207814 A CN A2006800207814A CN 200680020781 A CN200680020781 A CN 200680020781A CN 101193638 A CN101193638 A CN 101193638A
- Authority
- CN
- China
- Prior art keywords
- inhibitor
- pde
- tablet
- alpha
- controlled release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005016981.3 | 2005-04-13 | ||
DE102005016981A DE102005016981A1 (de) | 2005-04-13 | 2005-04-13 | Kombination zur Therapie bei benigner Prostatahyperplasie |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101193638A true CN101193638A (zh) | 2008-06-04 |
Family
ID=36608700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006800207814A Pending CN101193638A (zh) | 2005-04-13 | 2006-03-31 | 用于良性前列腺肥大疗法的组合 |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1888075A1 (es) |
JP (1) | JP2008535877A (es) |
KR (1) | KR20080007252A (es) |
CN (1) | CN101193638A (es) |
AR (1) | AR053575A1 (es) |
AU (1) | AU2006233567A1 (es) |
BR (1) | BRPI0610634A2 (es) |
CA (1) | CA2605224A1 (es) |
CR (1) | CR9427A (es) |
DE (1) | DE102005016981A1 (es) |
DO (1) | DOP2006000074A (es) |
GT (1) | GT200600145A (es) |
IL (1) | IL186604A0 (es) |
MA (1) | MA29683B1 (es) |
MX (1) | MX2007012567A (es) |
PE (1) | PE20061338A1 (es) |
RU (1) | RU2007141518A (es) |
SV (1) | SV2008002477A (es) |
TN (1) | TNSN07385A1 (es) |
TW (1) | TW200716122A (es) |
UY (1) | UY29473A1 (es) |
WO (1) | WO2006108519A1 (es) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727456A (zh) * | 2012-07-03 | 2012-10-17 | 北京科信必成医药科技发展有限公司 | 难溶性药物口腔崩解片及其制备方法 |
CN105338970A (zh) * | 2013-06-28 | 2016-02-17 | 韩美药品株式会社 | 包含他达拉非和坦洛新的药物胶囊复合制剂 |
CN106659690A (zh) * | 2014-06-30 | 2017-05-10 | 韩美药品株式会社 | 包括含有活性成分的膜包衣层的复合制剂 |
CN108066347A (zh) * | 2016-11-16 | 2018-05-25 | 深圳万和制药有限公司 | 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物 |
CN109843268A (zh) * | 2016-10-25 | 2019-06-04 | 韩国爱技特药业株式会社 | 含度他雄胺和他达拉菲的速效复合片剂 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143746A (en) * | 1994-01-21 | 2000-11-07 | Icos Corporation | Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use |
US20070093493A1 (en) * | 2005-10-12 | 2007-04-26 | Lilly Icos Llc | Treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
JP2009520806A (ja) * | 2005-12-21 | 2009-05-28 | ファイザー・プロダクツ・インク | PDE−5阻害薬と5−α還元酵素阻害薬の医薬組合せ |
CN101500572B (zh) * | 2006-07-07 | 2013-08-21 | 特瓦制药工业有限公司 | 包含他达拉非和至少一种载体的固体组合物 |
DE102007028869A1 (de) | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
EP2222301B1 (en) | 2007-12-13 | 2014-10-08 | Vanda Pharmaceuticals Inc. | Method and composition for treating an alpha adrenoceptor-mediated condition |
WO2009076664A1 (en) | 2007-12-13 | 2009-06-18 | Vanda Pharmaceuticals Inc. | Method and composition for treating a serotonin receptor-mediated condition |
US8885621B2 (en) | 2010-04-26 | 2014-11-11 | Intel Corporation | Method, apparatus and system for switching traffic streams among multiple bands |
WO2013123965A1 (en) * | 2012-02-20 | 2013-08-29 | Synthon Bv | A fixed dose pharmaceutical formulation |
MX2016001030A (es) | 2013-07-23 | 2016-10-07 | Allergan Inc | Métodos y composiciones que comprenden desmopresina en combinación con un agonista del receptor beta 3-adrenérgico. |
KR101663238B1 (ko) * | 2013-11-15 | 2016-10-14 | 한미약품 주식회사 | 타다라필 및 암로디핀을 포함하는 복합 고형 제제 |
WO2016003181A1 (ko) * | 2014-06-30 | 2016-01-07 | 한미약품 주식회사 | 활성성분-함유 필름 코팅층을 포함하는 복합제제 |
WO2016003180A1 (ko) * | 2014-06-30 | 2016-01-07 | 한미약품 주식회사 | 5-α-환원효소 억제제-함유 필름 코팅층을 포함하는 복합제제 및 그 제조방법 |
ES2923438T3 (es) * | 2014-11-20 | 2022-09-27 | Serenity Pharmaceuticals Llc | Composiciones que comprenden bajas dosis de desmopresina en combinación con un antagonista del receptor alfaadrenérgico |
KR102391495B1 (ko) * | 2016-03-31 | 2022-04-28 | 한미약품 주식회사 | 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제 |
KR101879133B1 (ko) * | 2017-07-11 | 2018-07-17 | (주)동구바이오제약 | 비뇨기 질환 예방 또는 치료용 제제 및 이의 제조방법 |
TR201715231A2 (tr) * | 2017-10-09 | 2019-04-22 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Dapokseti̇n ve fosfodi̇esteraz ti̇p-5 i̇nhi̇bi̇törü i̇çeren farmasöti̇k kombi̇nasyon |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050042177A1 (en) * | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
-
2005
- 2005-04-13 DE DE102005016981A patent/DE102005016981A1/de not_active Withdrawn
-
2006
- 2006-03-29 DO DO2006000074A patent/DOP2006000074A/es unknown
- 2006-03-31 CA CA002605224A patent/CA2605224A1/en not_active Abandoned
- 2006-03-31 MX MX2007012567A patent/MX2007012567A/es not_active Application Discontinuation
- 2006-03-31 WO PCT/EP2006/002941 patent/WO2006108519A1/de active Application Filing
- 2006-03-31 JP JP2008505765A patent/JP2008535877A/ja active Pending
- 2006-03-31 RU RU2007141518/15A patent/RU2007141518A/ru unknown
- 2006-03-31 BR BRPI0610634-0A patent/BRPI0610634A2/pt not_active Application Discontinuation
- 2006-03-31 EP EP06723901A patent/EP1888075A1/de not_active Withdrawn
- 2006-03-31 AU AU2006233567A patent/AU2006233567A1/en not_active Abandoned
- 2006-03-31 CN CNA2006800207814A patent/CN101193638A/zh active Pending
- 2006-03-31 KR KR1020077026260A patent/KR20080007252A/ko not_active Application Discontinuation
- 2006-04-07 SV SV2006002477A patent/SV2008002477A/es not_active Application Discontinuation
- 2006-04-10 GT GT200600145A patent/GT200600145A/es unknown
- 2006-04-11 AR ARP060101410A patent/AR053575A1/es unknown
- 2006-04-11 PE PE2006000383A patent/PE20061338A1/es not_active Application Discontinuation
- 2006-04-12 TW TW095112920A patent/TW200716122A/zh unknown
- 2006-04-12 UY UY29473A patent/UY29473A1/es not_active Application Discontinuation
-
2007
- 2007-10-09 CR CR9427A patent/CR9427A/es not_active Application Discontinuation
- 2007-10-11 TN TNP2007000385A patent/TNSN07385A1/en unknown
- 2007-10-11 IL IL186604A patent/IL186604A0/en unknown
- 2007-10-29 MA MA30335A patent/MA29683B1/fr unknown
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727456A (zh) * | 2012-07-03 | 2012-10-17 | 北京科信必成医药科技发展有限公司 | 难溶性药物口腔崩解片及其制备方法 |
CN102727456B (zh) * | 2012-07-03 | 2016-06-22 | 北京科信必成医药科技发展有限公司 | 药物口腔崩解片及其制备方法 |
CN105338970A (zh) * | 2013-06-28 | 2016-02-17 | 韩美药品株式会社 | 包含他达拉非和坦洛新的药物胶囊复合制剂 |
CN105338970B (zh) * | 2013-06-28 | 2019-07-09 | 韩美药品株式会社 | 包含他达拉非和坦洛新的药物胶囊复合制剂 |
CN106659690A (zh) * | 2014-06-30 | 2017-05-10 | 韩美药品株式会社 | 包括含有活性成分的膜包衣层的复合制剂 |
CN106659692A (zh) * | 2014-06-30 | 2017-05-10 | 韩美药品株式会社 | 包括含有活性成分的膜包衣层的复合制剂 |
CN106659690B (zh) * | 2014-06-30 | 2020-08-18 | 韩美药品株式会社 | 包括含有活性成分的膜包衣层的复合制剂 |
CN106659692B (zh) * | 2014-06-30 | 2020-08-18 | 韩美药品株式会社 | 包括含有活性成分的膜包衣层的复合制剂 |
CN109843268A (zh) * | 2016-10-25 | 2019-06-04 | 韩国爱技特药业株式会社 | 含度他雄胺和他达拉菲的速效复合片剂 |
CN109843268B (zh) * | 2016-10-25 | 2021-12-14 | 韩国爱技特药业株式会社 | 含度他雄胺和他达拉菲的速效复合片剂 |
CN108066347A (zh) * | 2016-11-16 | 2018-05-25 | 深圳万和制药有限公司 | 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CR9427A (es) | 2007-12-17 |
JP2008535877A (ja) | 2008-09-04 |
AU2006233567A1 (en) | 2006-10-19 |
CA2605224A1 (en) | 2006-10-19 |
AR053575A1 (es) | 2007-05-09 |
WO2006108519A1 (de) | 2006-10-19 |
GT200600145A (es) | 2007-04-10 |
IL186604A0 (en) | 2008-01-20 |
MX2007012567A (es) | 2007-12-10 |
DE102005016981A1 (de) | 2006-10-19 |
MA29683B1 (fr) | 2008-08-01 |
BRPI0610634A2 (pt) | 2010-07-13 |
EP1888075A1 (de) | 2008-02-20 |
SV2008002477A (es) | 2008-02-08 |
TNSN07385A1 (en) | 2009-03-17 |
TW200716122A (en) | 2007-05-01 |
PE20061338A1 (es) | 2007-01-28 |
KR20080007252A (ko) | 2008-01-17 |
UY29473A1 (es) | 2006-11-30 |
RU2007141518A (ru) | 2009-05-20 |
DOP2006000074A (es) | 2006-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101193638A (zh) | 用于良性前列腺肥大疗法的组合 | |
EP1138320B1 (de) | Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung | |
KR100364328B1 (ko) | 알푸조신 염산염의 제어방출 정제 | |
KR100618234B1 (ko) | 다공성 입자를 포함하는 제형 | |
CN103211779B (zh) | 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统 | |
JP2638303B2 (ja) | 異なる分子量を有するポリマー類を含んでなる投与形態 | |
DK170110B1 (da) | Farmaceutisk præparat med langsom frigivelse og anvendelse af fumarsyre til fremstilling af præpar atet | |
CA2616081C (en) | Gastroretentive formulations and manufacturing process thereof | |
AU2008310735B2 (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
CN101516351A (zh) | 含有卡比多巴和左旋多巴的缓释固态药物组合物 | |
US20070128276A1 (en) | Controlled release compositions comprising nimesulide | |
US20090124702A1 (en) | Pharmaceutical Compositions of Metformin | |
US20060099245A1 (en) | Hydrodynamically balancing oral drug delivery system with biphasic release | |
KR20090065524A (ko) | 프로그래머블 부력전달기술 | |
CN101785769A (zh) | 包含替米沙坦的固体药用制剂 | |
RU2580652C2 (ru) | Фармацевтическая композиция для орального введения | |
BG107538A (bg) | Дозирана лекарствена форма с хидрогелен механизъм | |
CN108201536A (zh) | 一种奥拉帕尼口服缓控释药物组合物及其用途 | |
CN101287452A (zh) | 包含1-(4-氯苯胺基)-4-(4-吡啶基甲基)-2,3-二氮杂萘和pH调节剂的固体药物组合物 | |
MXPA05004410A (es) | Composiciones de liberacion controlada. | |
CN110062628A (zh) | 一种瑞卡帕布口服缓控释药物组合物及其用途 | |
US20120003307A1 (en) | Levetiracetam controlled release composition | |
AU2004205184A1 (en) | Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping | |
Zahirul Khan | Recent trends and progress in sustained or controlled oral delivery of some water soluble drugs: morphine salts, diltiazem and captopril | |
CN110035751A (zh) | 一种维利帕尼缓控释药物组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1123485 Country of ref document: HK |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080604 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1123485 Country of ref document: HK |